Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a large decrease in short interest during the month of July. As of July 15th, there was short interest totaling 756 shares, a decrease of 66.6% from the June 30th total of 2,265 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 11,543 shares, the short-interest ratio is currently 0.1 days.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

Hedge funds and other institutional investors have recently modified their holdings of the company. Virtu Financial LLC purchased a new stake in shares of Fidelity Disruptive Medicine ETF during the 4th quarter worth about $228,000. Jane Street Group LLC raised its holdings in Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after buying an additional 44,630 shares during the period. Vise Technologies Inc. acquired a new position in Fidelity Disruptive Medicine ETF during the fourth quarter valued at approximately $234,000. Glass Jacobson Investment Advisors llc grew its stake in Fidelity Disruptive Medicine ETF by 44.0% during the fourth quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock worth $34,000 after buying an additional 385 shares during the period. Finally, BXM Wealth LLC purchased a new stake in Fidelity Disruptive Medicine ETF during the fourth quarter worth approximately $243,000.

Fidelity Disruptive Medicine ETF Stock Performance

Fidelity Disruptive Medicine ETF stock traded up $0.15 during midday trading on Monday, reaching $28.50. The stock had a trading volume of 1,254 shares, compared to its average volume of 11,941. Fidelity Disruptive Medicine ETF has a twelve month low of $22.80 and a twelve month high of $30.33. The stock has a market capitalization of $45.60 million, a PE ratio of 41.33 and a beta of 0.74. The stock’s 50-day simple moving average is $26.83 and its 200 day simple moving average is $26.09.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.